Skip to main content

Advertisement

SpringerLink
Log in

The relationship between quality of life and adherence to treatment

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension is a preventable condition, and the outcomes of clinical trials have established that its treatment reduces cardiovascular morbidity and mortality. Although awareness about the disease has improved in the past two decades, the reality is that many people remain untreated or not adequately controlled. The treatment of hypertension is usually long term, and its success will depend on the effects of the drug regimen on the patient’s quality of life. The relationship between quality of life and compliance is complex and merits careful study. Monitoring quality of life may be one of the best ways of improving adherence to treatment. Therefore, when developing an approach to the treatment of hypertension, physicians should take into consideration the impact of different antihypertensives on the patient’s overall well being, and along with the side effects and contraindications, quality-of-life issues may determine the choice of medication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Os I: Quality of life in hypertension. J Hum Hypertens 1994, 8(suppl 1):S27-S30.

    PubMed  Google Scholar 

  2. Leonetti G, Comerio G, Cuspidi C: Evaluating quality of life in hypertensive patients. J Cardiovasc Pharmacol 1994, 23(suppl 5):S54-S58.

    PubMed  CAS  Google Scholar 

  3. Hosie J, Wiklund I: Managing hypertension in general practice: can we do better? J Hum Hypertens 1995, 9:S15-S18.

    PubMed  Google Scholar 

  4. Bulpitt CJ, Fletcher AE: Quality of life evaluation of antihypertensive drugs. Pharmacoeconomics 1992, 2:95–102.

    Google Scholar 

  5. Bulpitt CJ, Fletcher AE: Quality-of-life instruments in hypertension. Pharmacoeconomics 1994, 6:523–535.

    PubMed  CAS  Google Scholar 

  6. Williams GH: Assessing patient wellness: new perspectives on quality of life and compliance. Am J Hypertens 1998, 11:186S-191S.

    Article  PubMed  CAS  Google Scholar 

  7. Kittler ME: Elderly hypertensives and quality of life: some methodological considerations. Eur Heart J 1994, 14:113–121.

    Google Scholar 

  8. Weber M: Guidelines for assessing outcomes of antihypertensive treatment. Am J Cardiol 1999, 84:2K-4K.

    Article  PubMed  CAS  Google Scholar 

  9. vanRossum CTM, van de Mheen H, Witteman JCM, et al.: Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension 2000, 35:814–821. A cross-sectional analysis of subjects in the Rotterdam Study revealed that 25% and 18% of hypertensive men and women, respectively, were not aware of having hypertension.

    PubMed  Google Scholar 

  10. Server P: The heterogeneity of hypertension: why doesn’t every patient respond to every antihypertensive drug? J Hum Hypertens 1995, 9:S33-S36.

    Google Scholar 

  11. Miller NH, Hill M, Kottke T, Ockene IS: The multilevel compliance challenge: recommendations for a call to action: a statement for healthcare professionals. Circulation 1997, 95:1085–1090.

    PubMed  CAS  Google Scholar 

  12. Testa MA: Methods and applications of quality-of-life measurement during antihypertensive therapy. Curr Hypertens Rep 2000, 2:530–537. According to the author of this study, the assessment of the pharmacologic effects of antihypertensive drugs on the patient’s wellness should focus on elements of health-related quality of life, which affect the patient’s compliance.

    PubMed  CAS  Google Scholar 

  13. Groog SH, Levine S, Testa MA, et al.: The effects of antihypertensive therapy on quality of life. N Engl J Med 1986, 314:1657–1664.

    Article  Google Scholar 

  14. Fletcher AE, Bulpitt CJ, Chase DM, et al.: Quality of life with three antihypertensive treatments - cilazapril, atenolol, nifedipine. Hypertension 1992, 19:499–507.

    PubMed  CAS  Google Scholar 

  15. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. BMJ 1985, 291:97–104.

    Article  Google Scholar 

  16. Testa MA, Hollenberg Nk, Anderson RB, et al.: Assessment by patient and spouse during antihypertensive therapy with atenolol and nifedipine GITS. Am J Hypertens 1991, 4:363–373.

    PubMed  CAS  Google Scholar 

  17. Bulpitt CJ, Fletcher AE: Quality of life evaluation of antihypertensive drugs. Pharmacoeconomics 1992, 2:95–102.

    Google Scholar 

  18. Bulpitt CJ, Connor M, Schulte M, Fletcher AE: Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life. J Hum Hypertens 2000, 14:205–212. s study compared the effects of the β-blocker bisoprolol versus the calcium channel blocker nifedipine on quality of life. The results of the study support the argument that β-blockers have an additional benefit in reducing tension and anxiety.

    Article  PubMed  CAS  Google Scholar 

  19. Vanmolkot, FHM, de Hoon JNJM, van de Ven LLM, Van BortelLMAB: Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide. J Hum Hypertens 1999, 13:559–563.

    Article  PubMed  CAS  Google Scholar 

  20. Testa MA, Hollenberg NK, Anderson RB, et al.: Assessment by patient and spouse during antihypertensive therapy with atenolol and nifedipine GITS. Am J Hypertens 1991, 4:363–373.

    PubMed  CAS  Google Scholar 

  21. Testa MA, Anderson RB, Nackley IF, et al.: Quality of life and antihypertensive therapy in men: a comparison of captopril and enalapril. N Engl J Med 1993, 328:907–913.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Care of the Elderly, Imperial College Faculty of Medicine, Hammersmith Campus, Du Cane Road, W12 0NN, London, UK

    Maria I. Nunes BSc, MSc

Authors
  1. Maria I. Nunes BSc, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nunes, M.I. The relationship between quality of life and adherence to treatment. Current Science Inc 3, 462–465 (2001). https://doi.org/10.1007/s11906-001-0007-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-001-0007-9

Keywords

Search

Navigation